Personal ECG solution approved by NICE for detecting signs of AFib

Anthony Vecchione | | Cardiovascular Business | Electrocardiography
Electrocardiograms analyzed by AI can offer information about mortality risk.

AliveCor, a California-based healthcare technology company focused on personal electrocardiogram (ECG) solutions, announced that the National Institute for Health and Care Excellence (NICE) is now recommending its KardiaMobile solution as a diagnostic tool for detecting signs of atrial fibrillation (AFib) in patients with suspected paroxysmal AFib. The new recommendation covers patients being treated by National Health Service providers in England and Wales. 

According to AliveCor, KardiaMobile is the first personal ECG to receive such a recommendation. The solution is used by patients through the Kardia smartphone app; they place two fingers from each hand on two top electrodes, providing a "medical-grade" recording of their heart activity. 

"AliveCor is proud to be able to offer the only NICE-recommended personal ECG to support remote cardiac care services for patients not in front of their cardiologist,” Priya Abani, AliveCor CEO, said in a prepared statement. "Today's recommendation not only highlights the clinical superiority of KardiaMobile against the current standard of care, but also its position as a more cost-effective solution, therefore warranting its value as a clinical tool to support rapid diagnosis of AFib."   

"AFib diagnosis rates across the U.K. pre-pandemic were already too low," Matt Reed, a specialist with NHS Lothian, added in the same statement. “With difficulties in accessing in-person care and increased waiting times, concern is that diagnosis rates have fallen further, leaving thousands of people at risk of life-threatening cardiovascular complications, such as an AFib-related stroke. With the NHS over-stretched, it is encouraging that NICE has recognized the value of utilizing smart technology to support clinicians."

Click here to read more about NICE recommendations. 

Anthony Vecchione

Related Content

Eko Health’s AI platform for digital stethoscopes granted new CPT code
FDA grants AI-powered ECG screening tool for aortic stenosis its breakthrough device designation
Homemade electrodes made of putty capture heart data as well as some commercial devices
JACC editor excited by progress during a 'very important moment' for cardiology
FDA clears new suite of ECG evaluation tools
PaceMate acquires Medtronic workflow tech, promising ‘unparalleled support’ for heart patients

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."